Zuo Gui Yin (Restore the Left (Kidney) Decoction)

Actions

Indications

Western Uses:

• What is Zuo Gui Yin used for in modern practice?

  In modern practice Zuo Gui Yin is referenced for conditions that present with the traditional Kidney-yin-deficiency pattern — particularly perimenopausal and menopausal symptoms (hot flashes, night sweats, dryness) associated with declining ovarian hormone production, where practitioners have traditionally applied its yin-nourishing action. Chinese laboratory research has examined the formula's effect on ovarian hormone pathways in aging animal models (see research).

  These biomedical correlates are offered as a reference to the formula’s traditional use, not as a claim that it treats any disease. Current research on Zuo Gui Yin itself is preclinical — animal and enzyme-activity studies (see research) — not human clinical trials. Any use for a diagnosed condition, and any combination with prescription medication, belongs with a qualified practitioner and appropriate medical care.

  Source: traditional-use correlates summarized from Bensky & Barolet, Formulas & Strategies; research correlates from PubMed (see research field). Reference only, not a treatment claim.

Originally Appeared In:

• Collected Treatises of Jing Yue (Jing Yue Quan Shu)

Notes:

• How is Zuo Gui Yin different from Liu Wei Di Huang Wan and Zuo Gui Wan?

  Zuo Gui Yin is Zhang Jingyue's purer, tonify-only reworking of Liu Wei Di Huang Wan. Liu Wei Di Huang Wan is built on a “three tonics, three drains” (san bu san xie) structure: Shu Di Huang, Shan Zhu Yu, and Shan Yao tonify, while Ze Xie, Mu Dan Pi, and Fu Ling each drain or offset one of the tonics. Zuo Gui Yin keeps the three tonics and keeps Fu Ling (as a Spleen-supporting assistant rather than a drain), but drops the two more overtly draining/clearing herbs — Ze Xie (drains Kidney/Bladder dampness) and Mu Dan Pi (clears Liver fire) — and adds Gou Qi Zi and Zhi Gan Cao. The net effect is a gentler, purer yin tonic for cases with no significant damp or fire signs to clear, versus Liu Wei Di Huang Wan's broader tonify-and-drain balance.

  • vs Liu Wei Di Huang Wan: choose Zuo Gui Yin when yin deficiency is essentially uncomplicated by damp or fire; choose Liu Wei Di Huang Wan when a milder draining/clearing action is still wanted alongside tonification.
  • vs Zuo Gui Wan: Zuo Gui Wan (same author) goes further — it removes all three of Liu Wei Di Huang Wan's draining herbs (Ze Xie, Fu Ling, and Mu Dan Pi) and adds stronger essence-building substances (Tu Si Zi, Chuan Niu Xi, and traditionally Gui Ban Jiao and Lu Jiao Jiao), formed into pills for sustained use in more severe or chronic Kidney yin-and-essence deficiency (e.g., marked low-back/knee weakness, seminal emission). Zuo Gui Yin, prepared as a lighter decoction, suits milder or more acute presentations and shorter courses.

  Source: Bensky & Barolet, Formulas & Strategies (formula derivation and comparisons); Sacred Lotus sources & references cross-checked against published Zuo Gui Yin/Zuo Gui Wan/Liu Wei Di Huang Wan ingredient lists.

Clinical Studies & Research:

• Is there modern research on Zuo Gui Yin?

  Yes, but it is preclinical — animal and enzyme-activity studies, mostly on aging/perimenopausal rat models, rather than human clinical trials. Chinese research groups have examined Zuo Gui Yin's (Zuoguiyin's) effect on ovarian hormone-production pathways in naturally aging rats used to model perimenopause, and separately its effect on drug-metabolizing liver enzymes.

  • Estradiol production (preclinical, rat model): in naturally aging peri-menopausal rats, medium and high doses of Zuo Gui Yin significantly increased serum estradiol and upregulated ovarian CYP19/P450(arom) expression, via ERα→LRH-1→CYP19 and FSHR→CYP19 pathways (PMID 21134435).
  • Ovarian VEGF/SPARC expression (preclinical, rat model): Zuoguiyin reduced elevated VEGF and restored SPARC expression in the aging ovary, proposed as a mechanism for delaying ovarian aging (PMID 20209964).
  • Drug-metabolizing enzymes (preclinical, rat model): a cocktail UPLC-MS/MS study found Zuo-Gui Yin Decoction induced CYP2C11 and CYP3A1 activity (human equivalents CYP2C19, CYP3A4) with no significant change to four other CYP450 isoforms tested — relevant to herb–drug interaction risk (PMID 36060135; PMC 9439930).

  Sources: PubMed 21134435; PubMed 20209964; PubMed 36060135 / PMC 9439930. Research context, not a therapeutic claim; all cited studies are preclinical (animal/enzyme models) and none establish efficacy for any human disease.